DCGI

Latest News

Government Explains ICMR’s Letter Giving August 15 Deadline For COVID-19 Vaccine Launch

Days after uproar over ICMR Director General’s letter envisaging the launch of COVID-19 vaccine by August 15, Union Health Ministry officials have now clarified that the intent of the letter…

View Post

Latest News

Glenmark Launches COVID-19 Drug FabiFlu After DCGI Nod

Glenmark Pharmaceuticals has launched antiviral drug Favipiravir, under the brand name FabiFlu, for the treatment of patients with mild to moderate COVID-19. The company has received manufacturing and marketing approval…

View Post

Latest News

Covid-19: DCGI Approves Emergency Use Of Gilead’s Remdesivir

Drug Controller General of India V.G. Somani has approved the use of Gilead Sciences Inc’s novel drug remdesivir to treat covid-19 patients, Lav Aggarwal, joint secretary in the health ministry…

View Post

Latest News

Zydus Cadila Gets DCGI Nod For Saroglitazar To Treat Liver Disease

Drugs maker Zydus Cadila on Thursday said it has received approval from the Drug Controller General of India (DCGI) for its new drug application for Saroglitazar to treat a particular…

View Post